As negative press continued to build for Purdue Pharma and the opioid crisis grew, their U.S. market shares began to shrink. Prescriptions for OxyContin fell more than 40% since 2010, equating to billions in lost revenue. The company’s owners, the Sackler Family, started pursuing a new strategy; go global through their international [...]